Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Transmedics Group, Inc. (TMDX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Transmedics Group, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Transmedics Group, Inc. since 2005.
The reporting company's ticker symbol is TMDX. The reporting company's CIK number is 1756262.
The total value of stock buying since 2005 is $669,328.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $3,164.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-09||Hassanein Waleed H (President & CEO)||Option Ex||6,000||.28||1,680|
|2019-08-09||Khayal Tamer I (Chief Commercial Officer)||Option Ex||1,300||.28||364|
|2019-06-13||Hassanein Waleed H (President & CEO)||Option Ex||4,000||.28||1,120|
|2019-05-06||Basile Edward M (Director)||Buy||8,500||16.00||136,000|
|2019-05-06||Kania Edwin M Jr (Director)||Buy||33,333||16.00||533,328|
Insider trading activities including stock purchases, stock sales, and option exercises of TMDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Transmedics Group, Inc. (symbol TMDX, CIK number 1756262) see the Securities and Exchange Commission (SEC) website.